[HTML] frontiersin.org

[HTML][HTML] High-content monitoring of drug effects in a 3D spheroid model

F Mittler, P Obeïd, AV Rulina, V Haguet, X Gidrol… - Frontiers in …, 2017 - frontiersin.org
A recent decline in the discovery of novel medications challenges the widespread use of 2D
monolayer cell assays in the drug discovery process. As a result, the need for more …
被引用次数：166 相关文章

High-Content Monitoring of Drug Effects in a 3D Spheroid Model

F Mittler, P Obeïd, AV Rulina, V Haguet, X Gidrol… - Frontiers in …, 2017 - hal.science
A recent decline in the discovery of novel medications challenges the widespread use of 2D
monolayer cell assays in the drug discovery process. As a result, the need for more …
[HTML] nih.gov

[HTML][HTML] High-Content Monitoring of Drug Effects in a 3D Spheroid Model

F Mittler, P Obeïd, AV Rulina, V Haguet… - Frontiers in …, 2017 - ncbi.nlm.nih.gov
A recent decline in the discovery of novel medications challenges the widespread use of 2D
monolayer cell assays in the drug discovery process. As a result, the need for more …

[引用][C] High-Content Monitoring of Drug Effects in a 3D Spheroid Model

F Mittler, P Obeïd, AV Rulina, V Haguet, X Gidrol… - Frontiers in …, 2017 - cir.nii.ac.jp

High-Content Monitoring of Drug Effects in a 3D Spheroid Model

F Mittler, P Obeïd, AV Rulina, V Haguet… - Frontiers in …, 2017 - pubmed.ncbi.nlm.nih.gov
A recent decline in the discovery of novel medications challenges the widespread use of 2D
monolayer cell assays in the drug discovery process. As a result, the need for more …

High-Content Monitoring of Drug Effects in a 3D Spheroid Model.

F Mittler, P Obeïd, AV Rulina, V Haguet… - Frontiers in …, 2017 - europepmc.org
A recent decline in the discovery of novel medications challenges the widespread use of 2D
monolayer cell assays in the drug discovery process. As a result, the need for more …